<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Ann Clin Transl Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">Ann Clin Transl Neurol</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)2328-9503</journal-id>
<journal-id journal-id-type="publisher-id">ACN3</journal-id>
<journal-title-group>
<journal-title>Annals of Clinical and Translational Neurology</journal-title>
</journal-title-group>
<issn pub-type="epub">2328-9503</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28078312</article-id>
<article-id pub-id-type="pmc">5221474</article-id>
<article-id pub-id-type="doi">10.1002/acn3.372</article-id>
<article-id pub-id-type="publisher-id">ACN3372</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Research Paper</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Research Papers</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Biallelic <italic><styled-content style="fixed-case">SCN</styled-content>10A</italic> mutations in neuromuscular disease and epileptic encephalopathy</article-title>
<alt-title alt-title-type="left-running-head">M. Kambouris <italic>et al</italic>.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="acn3372-cr-0001">
<name>
<surname>Kambouris</surname>
<given-names>Marios</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acn3372-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="acn3372-aff-0003">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="acn3372-note-1001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0002">
<name>
<surname>Thevenon</surname>
<given-names>Julien</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0004">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="acn3372-note-1001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0003">
<name>
<surname>Soldatos</surname>
<given-names>Ariane</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0005">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="acn3372-aff-0006">
<sup>6</sup>
</xref>
<xref ref-type="author-notes" rid="acn3372-note-1001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0004">
<name>
<surname>Cox</surname>
<given-names>Allison</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0007">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0005">
<name>
<surname>Stephen</surname>
<given-names>Joshi</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0006">
<name>
<surname>Ben‐Omran</surname>
<given-names>Tawfeg</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0008">
<sup>8</sup>
</xref>
<xref ref-type="aff" rid="acn3372-aff-0009">
<sup>9</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0007">
<name>
<surname>Al‐Sarraj</surname>
<given-names>Yasser</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0008">
<name>
<surname>Boulos</surname>
<given-names>Hala</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0010">
<sup>10</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0009">
<name>
<surname>Bone</surname>
<given-names>William</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0010">
<name>
<surname>Mullikin</surname>
<given-names>James C.</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0011">
<sup>11</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0011">
<collab collab-type="authors">NISC Comparative Sequencing Program</collab>
<xref ref-type="aff" rid="acn3372-aff-0011">
<sup>11</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0012">
<name>
<surname>Masurel‐Paulet</surname>
<given-names>Alice</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0013">
<name>
<surname>St‐Onge</surname>
<given-names>Judith</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0014">
<name>
<surname>Dufford</surname>
<given-names>Yannis</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0015">
<name>
<surname>Chantegret</surname>
<given-names>Corrine</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0016">
<name>
<surname>Thauvin‐Robinet</surname>
<given-names>Christel</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0017">
<name>
<surname>Al‐Alami</surname>
<given-names>Jamil</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0012">
<sup>12</sup>
</xref>
<xref ref-type="author-notes" rid="acn3372-note-1002">
<sup>‡</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0018">
<name>
<surname>Faivre</surname>
<given-names>Laurence</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0019">
<name>
<surname>Riviere</surname>
<given-names>Jean Baptiste</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0020">
<name>
<surname>Gahl</surname>
<given-names>William A.</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0005">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="acn3372-aff-0006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0021">
<name>
<surname>Bassuk</surname>
<given-names>Alexander G.</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0007">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acn3372-cr-0022">
<name>
<surname>Malicdan</surname>
<given-names>May Christine V.</given-names>
</name>
<xref ref-type="aff" rid="acn3372-aff-0006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="acn3372-cr-0023">
<name>
<surname>El‐Shanti</surname>
<given-names>Hatem</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6230-8316</contrib-id>
<address>
<email>h.elshanti@ju.edu.jo</email>
</address>
<xref ref-type="aff" rid="acn3372-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="acn3372-aff-0007">
<sup>7</sup>
</xref>
<xref ref-type="aff" rid="acn3372-aff-0013">
<sup>13</sup>
</xref>
</contrib>
</contrib-group>
<aff id="acn3372-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Pathology‐Genetics</named-content>
<institution>Sidra Medical and Research Center</institution>
<named-content content-type="city">Doha</named-content>
<country country="QA">Qatar</country>
</aff>
<aff id="acn3372-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Qatar Biomedical Research Institute</named-content>
<institution>Medical Genetics Center</institution>
<institution>Hamad Bin Khalifa University</institution>
<named-content content-type="city">Doha</named-content>
<country country="QA">Qatar</country>
</aff>
<aff id="acn3372-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Genetics</named-content>
<institution>Yale University School of Medicine</institution>
<named-content content-type="city">New Haven</named-content>
<named-content content-type="country-part">Chicago</named-content>
</aff>
<aff id="acn3372-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Centre de Génétique</named-content>
<institution>Hôpital d'Enfant</institution>
<named-content content-type="city">Dijon</named-content>
<country country="FR">France</country>
</aff>
<aff id="acn3372-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Medical Genetics Branch</named-content>
<institution>National Human Genome Research Institute</institution>
<institution>National Institutes of Health</institution>
<named-content content-type="city">Bethesda</named-content>
<named-content content-type="country-part">Maryland</named-content>
</aff>
<aff id="acn3372-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Undiagnosed Diseases Program</named-content>
<institution>National Human Genome Research Institute</institution>
<institution>National Institutes of Health</institution>
<named-content content-type="city">Bethesda</named-content>
<named-content content-type="country-part">Maryland</named-content>
</aff>
<aff id="acn3372-aff-0007">
<label>
<sup>7</sup>
</label>
<named-content content-type="organisation-division">Pediatrics</named-content>
<institution>University of Iowa</institution>
<named-content content-type="city">Iowa City</named-content>
<named-content content-type="country-part">Iowa</named-content>
</aff>
<aff id="acn3372-aff-0008">
<label>
<sup>8</sup>
</label>
<named-content content-type="organisation-division">Clinical and Metabolic Genetics</named-content>
<institution>Pediatrics</institution>
<institution>Hamad Medical Corporation</institution>
<named-content content-type="city">Doha</named-content>
<country country="QA">Qatar</country>
</aff>
<aff id="acn3372-aff-0009">
<label>
<sup>9</sup>
</label>
<institution>Weill Cornell Medical College</institution>
<named-content content-type="city">Doha</named-content>
<country country="QA">Qatar</country>
</aff>
<aff id="acn3372-aff-0010">
<label>
<sup>10</sup>
</label>
<named-content content-type="organisation-division">Human Genetics</named-content>
<institution>University of Chicago</institution>
<named-content content-type="city">Chicago</named-content>
<named-content content-type="country-part">Illinois</named-content>
</aff>
<aff id="acn3372-aff-0011">
<label>
<sup>11</sup>
</label>
<named-content content-type="organisation-division">Intramural Sequencing Center and Comparative Genomics Unit</named-content>
<named-content content-type="organisation-division">Genome Technology Branch</named-content>
<institution>National Genome Research Institute</institution>
<institution>National Institutes of Health</institution>
<named-content content-type="city">Bethesda</named-content>
<named-content content-type="country-part">Maryland</named-content>
</aff>
<aff id="acn3372-aff-0012">
<label>
<sup>12</sup>
</label>
<institution>Shafallah Medical Genetics Center</institution>
<named-content content-type="city">Doha</named-content>
<country country="QA">Qatar</country>
</aff>
<aff id="acn3372-aff-0013">
<label>
<sup>13</sup>
</label>
<named-content content-type="organisation-division">Pediatrics</named-content>
<institution>University of Jordan</institution>
<named-content content-type="city">Amman</named-content>
<country country="JO">Jordan</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Hatem El‐Shanti, Department of Pediatrics, School of Medicine, University of Jordan, Amman, Jordan. Tel: +962 79 715 9170; Fax: +962 6 530 0820; E‐mail: <email>h.elshanti@ju.edu.jo</email><break></break></corresp>
<fn fn-type="equal" id="acn3372-note-1001">
<label>†</label>
<p>Equal contribution.</p>
</fn>
<fn id="acn3372-note-1002">
<label>‡</label>
<p>Deceased.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<month>1</month>
<year>2017</year>
</pub-date>
<volume>4</volume>
<issue>1</issue>
<issue-id pub-id-type="doi">10.1002/acn3.2017.4.issue-1</issue-id>
<fpage>26</fpage>
<lpage>35</lpage>
<history>
<date date-type="received">
<day>17</day>
<month>6</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>02</day>
<month>10</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>10</month>
<year>2016</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2017 American Neurological Association <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2016 The Authors. <italic>Annals of Clinical and Translational Neurology</italic> published by Wiley Periodicals, Inc on behalf of American Neurological Association.</copyright-statement>
<license license-type="creativeCommonsBy-nc-nd">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution‐NonCommercial‐NoDerivs</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:ACN3-4-26.pdf" xlink:type="simple"></self-uri>
<abstract id="acn3372-abs-0001">
<title>Abstract</title>
<sec id="acn3372-sec-0001">
<title>Objectives</title>
<p>Two consanguineous families, one of Sudanese ethnicity presenting progressive neuromuscular disease, severe cognitive impairment, muscle weakness, upper motor neuron lesion, anhydrosis, facial dysmorphism, and recurrent seizures and the other of Egyptian ethnicity presenting with neonatal hypotonia, bradycardia, and recurrent seizures, were evaluated for the causative gene mutation.</p>
</sec>
<sec id="acn3372-sec-0002">
<title>Methods and Results</title>
<p>Homozygosity mapping and whole exome sequencing (<styled-content style="fixed-case">WES</styled-content>) identified damaging homozygous variants in <italic><styled-content style="fixed-case">SCN</styled-content>10A</italic>, namely c.4514C&gt;T; p.Thr1505Met in the first family and c.4735C&gt;T; p.Arg1579* in the second family. A third family, of Western European descent, included a child with febrile infection‐related epilepsy syndrome (<styled-content style="fixed-case">FIRES</styled-content>) who also had compound heterozygous missense mutations in <italic><styled-content style="fixed-case">SCN</styled-content>10A</italic>, namely, c.3482T&gt;C; p.Met1161Thr and c.4709C&gt;A; p.Thr1570Lys. A search for <italic><styled-content style="fixed-case">SCN</styled-content>10A</italic> variants in three consortia datasets (Euro<styled-content style="fixed-case">EPINOMICS</styled-content>, Epi4K/<styled-content style="fixed-case">EPGP</styled-content>, Autism/dbGaP) identified an additional five individuals with compound heterozygous variants. A Hispanic male with infantile spasms [c.2842G&gt;C; p.Val948Leu and c.1453C&gt;T; p.Arg485Cys], and a Caucasian female with Lennox–Gastaut syndrome [c.1529C&gt;T; p.Pro510Leu and c.4984G&gt;A; p.Gly1662Ser] in the epilepsy databases and three in the autism databases with [c.4009T&gt;A; p.Ser1337Thr and c.1141A&gt;G; p.Ile381Val], [c.2972C&gt;T; p.Pro991Leu and c.2470C&gt;T; p.His824Tyr], and [c.4009T&gt;A; p.Ser1337Thr and c.2052G&gt;A; p.Met684Ile].</p>
</sec>
<sec id="acn3372-sec-0003">
<title>Interpretation</title>
<p>
<italic><styled-content style="fixed-case">SCN</styled-content>10A</italic> is a member of the voltage‐gated sodium channel (<styled-content style="fixed-case">VGSC</styled-content>) gene family. Sodium channels are responsible for the instigation and proliferation of action potentials in central and peripheral nervous systems. Heterozygous mutations in <styled-content style="fixed-case">VGSC</styled-content> genes cause a wide range of epileptic and peripheral nervous system disorders. This report presents autosomal recessive mutations in <italic><styled-content style="fixed-case">SCN</styled-content>10A</italic> that may be linked to epilepsy‐related phenotypes, Lennox–Gastaut syndrome, infantile spasms, and Autism Spectrum Disorder.</p>
</sec>
</abstract>
<funding-group>
<award-group>
<funding-source>Qatar National Research Fund</funding-source>
<award-id>09‐367‐3‐087</award-id>
<award-id>6‐359‐3‐095</award-id>
</award-group>
<award-group>
<funding-source>Shafallah Center Foundation</funding-source>
</award-group>
<award-group>
<funding-source>NIH</funding-source>
<award-id>1R01 NS064159‐01A1</award-id>
<award-id>5R21MH100086‐02</award-id>
</award-group>
<award-group>
<funding-source>National Human Genome Research Institute Intramural Research Program</funding-source>
</award-group>
<award-group>
<funding-source>Autism Sequencing Collaborative</funding-source>
<award-id>R01‐MH089208</award-id>
<award-id>R01‐MH089175</award-id>
<award-id>R01‐MH089025</award-id>
<award-id>R01‐MH089004</award-id>
<award-id>R01‐MH089482</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="2"></table-count>
<page-count count="10"></page-count>
<word-count count="5702"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>acn3372</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>January 2017</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.0.0 mode:remove_FC converted:09.01.2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="acn3372-sec-0004">
<title>Introduction</title>
<p>Four patients from three different families with epilepsy and biallelic <italic>SCN10A</italic> variants were identified. Family 1 (Fig. <xref ref-type="fig" rid="acn3372-fig-0001">1</xref>A) is Sudanese, seen at the Shafallah Medical Genetics Center, Doha, Qatar; two female siblings (II‐6, 18 years and II‐7, 17 years) presented with progressive neuromuscular symptoms and impaired intellectual development. The parents, first cousins, previously had one second‐trimester spontaneous abortion and a daughter who died 4 days after birth. Shortly after birth, patient II‐6 had recurrent attacks of high‐grade fever and absent tearing. She was recognized to be hypotonic at 4 months of age and she was able to walk only at 20 months of age. At the age of 10 years, she developed progressive weakness and difficulty swallowing that led to aspiration pneumonia and frequent hospitalizations. She stopped being ambulatory at the age of 14 years, and her speech became slurred and had notable intellectual impairment. Dysmorphic features included a prominent forehead, long face, and broad nasal bridge. The muscle tone was decreased but with retained deep tendon reflexes and bilateral up‐going plantar reflex. Patient II‐7 had a clinical presentation similar to that of her older sister, but with the onset of seizures at the age of 15 years, described as drop attacks with neck extension, eyes rolling back, and intermittent myoclonus and poor response to combinations of anti‐epileptic drugs, with a modest response to lamotrigine and topiramate. Both sisters had normal Creatine Phosphokinase (CPK), liver function tests, serum lactate, serum amino acids, ammonia, brain MRI, electromyogram (EMG), and nerve conduction studies (NCS). For II‐6, ophthalmologic evaluation did not show any retinal abnormalities and echocardiography was unremarkable. Electron microscopy of a skin biopsy ruled out anhidrotic ectodermal dysplasia. For II‐7 the electroencephalogram (EEG) showed generalized subcortical epileptiform discharges. Chromosomal analysis and molecular karyotyping did not reveal any copy number variants (CNVs) of clinical significance, especially within the homozygosity regions.</p>
<fig fig-type="Figure" id="acn3372-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>Pedigree of families 1 (A), 2 (B), and 3 (C) with the seggregating <italic><styled-content style="fixed-case">SCN</styled-content>10A</italic> mutations. Genotypes are indicated below each participating individual. Double lines represent first cousin marriage.</p>
</caption>
<graphic id="nlm-graphic-1" xlink:href="ACN3-4-26-g001"></graphic>
</fig>
<p>Family 2 (Fig. <xref ref-type="fig" rid="acn3372-fig-0001">1</xref>B) represented a consanguineous marriage of Egyptian first cousins seen at Hôpital d'Enfant, Dijon, France. The family had several infantile deaths previously. In utero, the proband (II‐3) had third trimester fetal sinus bradycardia without maternal lupus erythematosis. She was born at 37 weeks with normal length, weight and head circumference, and profound hypotonia, absent deep tendon reflexes but no tongue fasciculation. The only facial dysmorphism was a tented upper lip. She was admitted to the intensive care unit for recurrent apnea, bradycardia and poor feeding. The echocardiography showed a patent foramen ovale. Brain MRI, ophthalmological examination, abdominal ultrasound, bone survey, electroretinogram (ERG), EMG, EEG, visual, and auditory evoked potentials, metabolic screen, mitochondrial screen, muscle enzymes, cerebrospinal fluid investigations, including neurotransmitter assays, and muscle, and liver biopsies were all normal. At 3 months of age, the patient remained hypotonic with feeding difficulties. There was no eye contact or head control, but there was plastic rigidity and abnormal ocular movements. The EEG showed modifications in basal rhythm with rare and bilateral inner temporal spikes. Several weeks later, she had tonic spasms and tonic‐clonic seizures. A follow‐up EEG revealed generalized spike‐wave discharges without hypsarrhythmia. The seizures were difficult to control with three different anti‐epileptic drugs (phenobarbital, diazepam and dilantin), and progressed to recurrent episodes of status epilepticus. Chromosomal and molecular karyotyping were unremarkable. DNA testing for <italic>SMN</italic>,<italic> CDKL5</italic>, and <italic>FOXG1</italic> was negative, thus ruling out spinal muscular atrophy, X‐linked infantile spasms and FOXG1 syndromes. The patient died at 6 months of age.</p>
<p>The third family (Fig. <xref ref-type="fig" rid="acn3372-fig-0001">1</xref>C) is of Portuguese and Italian descent. The male proband (II‐1) was developmentally appropriate without medical issues until the abrupt onset of febrile flu‐like prodrome at the age of 6 years, and 5 days after the onset of the fever he was found unresponsive; this immediately progressed to intractable multifocal epilepsy requiring prolonged placement in a medically induced coma with intravenous midazolam, ketamine, paraldehyde, and phenobarbital titrated to burst‐suppression such that he required inotropic support with other treatment attempts such as hypothermia and ketogenic diet. Brain MRI showed abnormal T2 signal with restricted diffusion in both hippocampi, right greater that left. MRS showed an increased glutamine‐glutamate peak possibly representing excitotoxic neuronal changes. A PET scan showed markedly abnormal focal uptake in the left parieto‐occipital region, moderately diffused increased uptake in the left hemisphere, multiple foci of FDG accumulation, and diffusely decreased uptake in the anterior right temporal lobe. The CSF showed 7 WBCs, 2 RBCs, glucose 3.8 mmol/L, protein 0.28 mg/dL. Extensive infectious testing was negative and diagnostic brain biopsy was unremarkable. Visual evoked potentials showed no clearly reproducible cortical response. Somatosensory‐evoked potential of the median nerve showed very low cortical response. Brainstem auditory evoked potential responses were normal. 3 months into the illness, he had choreiform movements. He remains neurologically devastated with frequent seizures requiring intravenous anti‐epileptic drugs, vagal nerve stimulation, and chronic ventilation via tracheostomy.</p>
</sec>
<sec id="acn3372-sec-0005">
<title>Material and Methods</title>
<p>The study was conducted in accordance with the provisions of the Declaration of Helsinki and a signed informed consent was obtained from each participant or his/her legal guardian. Blood samples from all available family members of the three families were obtained and genomic DNA was extracted with Gentra Puregene Blood kit [Qiagen, Valencia, CA] according to the manufacturer's specifications and guidelines.</p>
<p>Homozygosity mapping was performed utilizing the Human Mapping OmniExpress‐12 v1‐1 SNP genotyping array [Illumina, San Diego, CA]. Data iltration and genotyping were done with GenomeStudio v2011.1. For the determination of linkage intervals, data were analyzed by the “HomozygosityMapper” software.<xref ref-type="ref" rid="acn3372-bib-0001">1</xref>, <xref ref-type="ref" rid="acn3372-bib-0002">2</xref>
</p>
<p>For families 1 and 2, whole exome target enrichment was performed on ABI SOLiD™ 4 platform (Applied Biosystems, Foster City, CA) according to the manufacturer's specifications. DNA library preparation was with TargetSeq™ Exome Enrichment system (Applied Biosystems) as multiplex fragment libraries utilizing both the SOLiD™ Fragment Library construction Kits and SOLiD™ Fragment Library Barcoding Kit Module 1–16 for the ABI SOLiD™ 4 system. Bead preparation and enriching was done on an EZ Bead Emulsifier, Amplifier and Enricher utilizing E80 scale (Applied Biosystems). Sequencing modality was with multiplex fragment paired‐end.</p>
<p>The bioinformatics of the whole exome NGS data started with the analysis of the raw data files (in a proprietary XSQ format) with the Life Technologies LifeScope v2.5.4 software (Life Technologies, Carlsbad, CA) on a dedicated cluster to align the reads produced by the SOLiD™ to the hg19 reference sequence, sourced from the University of California at Santa Cruz Genome Informatics Group (UCSC). The aligned (BAM) files were validated, duplicate sequences were identified and removed and incorrectly identified Mate‐Pairs were corrected, using the Picard v1.87 software. The Genome Analysis Tool Kit (GATK) v.3.0.0 (Boston, MA, USA) was applied to the “corrected” output files to recalibrate the base quality scores, using machine learning to model any systematic errors in the data, to carry out localized realignments around possible insertion/deletion sequences to ensure mapping accuracy, to identify viable variants from the sequence reads and to recalibrate the variants to ensure accuracy of the variant calling in a variant‐specific manner. Once a suitable list of variants was produced, it was filtered using in‐house scripts to confirm variant zygosity and identify those variants that conform to the inheritance model. These variants were annotated using an in‐house script in conjunction with the software, ANNOVAR [<ext-link ext-link-type="uri" xlink:href="http://www.openbioinformatics.org/annovar/">http://www.openbioinformatics.org/annovar/</ext-link>] to produce an annotated variant list with the most recent available information from a number of reference Websites.</p>
<p>Whole Exome sequencing for Family 3 was performed on Illumina HiSeq2000 (Illumina) with 101‐bp paired‐end read sequencing. Image analyses and base calling were with the Illumina Genome Analyzer Pipeline software v.1.13.48.0 with default parameters. Reads were aligned to a human reference sequence (UCSC hg19; NCBI build 37) with the “Efficient Large‐scale Alignment of Nucleotide Databases” software (Illumina). Genotypes were called at all positions with high‐quality sequence bases using the Bayesian algorithm “Most Probable Genotype.” The BAM files were visualized with Integrative Genomics Viewer (The Broad Institute, Cambridge, MA). Variants were filtered using VarSifter v1.5 tool by considering minor allele frequency (MAF) of &lt;0.05 and the availability of variants in public databases of dbSNP, ClinSeq and EXAC (The Broad Institute). Filtered variants were annotated with CADD score using online tools [<ext-link ext-link-type="uri" xlink:href="http://cadd.gs.washington.edu/score">http://cadd.gs.washington.edu/score</ext-link>].</p>
<p>Targeted DNA resequencing was done by Sanger Big‐dye terminator v3.1 cycle sequencing (Applied Biosystems) on an ABI 3730 automatic sequencer (Applied Biosystems) to screen for mutations in candidate genes, perform allele frequency studies in related populations, and determine co‐segregation of variants with the phenotype within each family.</p>
<p>VCF files were obtained from the dbGaP entry for the ARRA Autism Sequencing Collaboration (phs000298). Only those consented for autism research (AO) were downloaded. The dataset(s) were deposited by the ARRA Autism Sequencing Collaborative, an ARRA funded research initiative. Exome VCF files from the Epi4K Epilepsy Phenome/Genome Project (EPGP) were requested and downloaded from the dbGaP (phs000653 v2p1).<xref ref-type="ref" rid="acn3372-bib-0003">3</xref>, <xref ref-type="ref" rid="acn3372-bib-0004">4</xref>, <xref ref-type="ref" rid="acn3372-bib-0005">5</xref>
</p>
</sec>
<sec id="acn3372-sec-0006">
<title>Results</title>
<p>The SNP genotyping and homozygosity mapping for Family 1 identified four intervals spanning about 70 Mb and containing about 850 protein‐coding genes (Table <xref ref-type="table-wrap" rid="acn3372-tbl-0001">1</xref>). The WES for II‐6 showed no significant de novo or X‐linked variants but identified two exonic nonsynonymous homozygous variants within the homozygosity intervals, <italic>DYNC2H</italic>: c.12254G&gt;A; p.Arg4085His and <italic>SCN10A</italic>: c.4514C&gt;T; p.Thr1505Met.</p>
<table-wrap id="acn3372-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Homozygosity intervals for families 1 &amp; 2</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Family</th>
<th align="left" colspan="1" rowspan="1" valign="top">Chromosome</th>
<th align="left" colspan="1" rowspan="1" valign="top">From coordinates</th>
<th align="left" colspan="1" rowspan="1" valign="top">To coordinates</th>
<th align="left" colspan="1" rowspan="1" valign="top">Length [Mb]</th>
<th align="left" colspan="1" rowspan="1" valign="top">Protein‐Coding gene number</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="6" rowspan="1">Family 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">3p</td>
<td align="left" colspan="1" rowspan="1">
32,417,644<break></break>
rs4364205
</td>
<td align="left" colspan="1" rowspan="1">
51,874,275<break></break>
rs9853511
</td>
<td align="left" colspan="1" rowspan="1">19.5</td>
<td align="left" colspan="1" rowspan="1">235</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">11p</td>
<td align="left" colspan="1" rowspan="1">
41,180,155<break></break>
rs10768669
</td>
<td align="left" colspan="1" rowspan="1">
66,262,606<break></break>
rs2511224
</td>
<td align="left" colspan="1" rowspan="1">25.1</td>
<td align="left" colspan="1" rowspan="1">391</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">11q</td>
<td align="left" colspan="1" rowspan="1">
102,385,738<break></break>
rs7118775
</td>
<td align="left" colspan="1" rowspan="1">
123,074,915<break></break>
rs485345
</td>
<td align="left" colspan="1" rowspan="1">20.7</td>
<td align="left" colspan="1" rowspan="1">171</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">14q</td>
<td align="left" colspan="1" rowspan="1">
101,679,885<break></break>
rs8015515
</td>
<td align="left" colspan="1" rowspan="1">
107,246,846<break></break>
rs2078693
</td>
<td align="left" colspan="1" rowspan="1">5.6</td>
<td align="left" colspan="1" rowspan="1">57</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1">Family 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">1p</td>
<td align="left" colspan="1" rowspan="1">
117,010,232<break></break>
rs17575616
</td>
<td align="left" colspan="1" rowspan="1">
164,541,977<break></break>
rs2792251
</td>
<td align="left" colspan="1" rowspan="1">47.5</td>
<td align="left" colspan="1" rowspan="1">456</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">3p</td>
<td align="left" colspan="1" rowspan="1">
8,734,471<break></break>
rs6766036
</td>
<td align="left" colspan="1" rowspan="1">
57,499,769<break></break>
rs6445905
</td>
<td align="left" colspan="1" rowspan="1">48.8</td>
<td align="left" colspan="1" rowspan="1">419</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">5q</td>
<td align="left" colspan="1" rowspan="1">
111,893,837<break></break>
rs7703562
</td>
<td align="left" colspan="1" rowspan="1">
115,949,578<break></break>
rs1873853
</td>
<td align="left" colspan="1" rowspan="1">4</td>
<td align="left" colspan="1" rowspan="1">22</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>The SNP genotyping and homozygosity mapping for Family 2 identified three intervals spanning about 100 Mb and containing about 880 protein‐coding genes (Table <xref ref-type="table-wrap" rid="acn3372-tbl-0001">1</xref>). The WES for II‐3 showed no significant de novo or X‐linked variants but identified two exonic nonsynonymous homozygous variants within the homozygosity intervals, <italic>LAMB2</italic>: c.4981C&gt;T; p.Arg1661Trp and <italic>SCN10A</italic>: c.4735C&gt;T; p.Arg1579*.</p>
<p>The WES and comparative genome analyses for Family 3 showed no significant de novo, homozygous or X‐linked variants. Compound heterozygous exonic nonsynonymous variants were identified in <italic>SASH1</italic>: c.2458C&gt;T; p.Arg820Trp and c.2995G&gt;A; p.Gly999Arg, and in <italic>SCN10A</italic>: c.3482T&gt;C; p.Met1161Thr and c.4709C&gt;A; p.Thr1570Lys.</p>
<p>Following the identification of the <italic>SCN10A</italic> variants in the three families, three consortia databases were examined for compound heterozygous variants in <italic>SCN10A</italic>. The Epi4K/EPGP dataset,<xref ref-type="ref" rid="acn3372-bib-0004">4</xref> containing WES data on 356 patients, identified <italic>SCN10A</italic> compound heterozygous variants in two patients; a Caucasian female with Lennox‐Gastaut syndrome (LGS, MIM 606369) [c.1529C&gt;T; p.Pro510Leu and c.4984G&gt;A; p.Gly1662Ser] and a Hispanic male with infantile spasms [c.2842G&gt;C; p.Val948Leu and c.1453C&gt;T; p.Arg485Cys]. The Autism dbGaP dataset, containing WES data from 486 patients with ASD, identified <italic>SCN10A</italic> compound heterozygous variants in three patients; [c.4009T&gt;A; p.Ser1337Thr and c.1141A&gt;G; p.Ile381Val], [c.2972C&gt;T; p.Pro991Leu and c.2470C&gt;T; p.His824Tyr], and [c.4009T&gt;A; p.Ser1337Thr and c.2052G&gt;A; p.Met684Ile]. The MAFs of all identified variants, the in silico mutation effect predictions and amino‐acid conservation across species are presented in Table <xref ref-type="table-wrap" rid="acn3372-tbl-0002">2</xref>. The positions of all protein variants are shown in Figure <xref ref-type="fig" rid="acn3372-fig-0002">2</xref>.</p>
<table-wrap id="acn3372-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>
<italic>SCN10A</italic> variants</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Patient</th>
<th align="left" colspan="1" rowspan="1" valign="top"></th>
<th align="left" colspan="1" rowspan="1" valign="top">dbID</th>
<th align="left" colspan="1" rowspan="1" valign="top">cDNA (NM_006514.3)</th>
<th align="left" colspan="1" rowspan="1" valign="top">PROTEIN</th>
<th align="left" colspan="1" rowspan="1" valign="top">MAF in Exac</th>
<th align="left" colspan="1" rowspan="1" valign="top">POLYPHEN</th>
<th align="left" colspan="1" rowspan="1" valign="top">POLYPHEN SCORE (HumDiv/HumVar)</th>
<th align="left" colspan="1" rowspan="1" valign="top">SIFT</th>
<th align="left" colspan="1" rowspan="1" valign="top">SIFT SCORE</th>
<th align="left" colspan="1" rowspan="1" valign="top">Mutation Taster</th>
<th align="left" colspan="1" rowspan="1" valign="top">PhyloP conservation score</th>
<th align="left" colspan="1" rowspan="1" valign="top">Phastcons conservation score</th>
<th align="left" colspan="1" rowspan="1" valign="top">CONSERV‐ATION OF AMINO ACID</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="14" rowspan="1">Compound heterozygous variants in families included in the study</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:15%">Family 1</td>
<td align="left" colspan="1" rowspan="1">1 &amp; 2</td>
<td align="left" colspan="1" rowspan="1">rs184521520</td>
<td align="left" colspan="1" rowspan="1">c.4514C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.Thr1505Met</td>
<td align="left" colspan="1" rowspan="1">T: 0.00045</td>
<td align="left" colspan="1" rowspan="1">Probably damaging</td>
<td align="left" colspan="1" rowspan="1">1/0.961</td>
<td align="left" colspan="1" rowspan="1">Deleterious</td>
<td align="left" colspan="1" rowspan="1">0.01</td>
<td align="left" colspan="1" rowspan="1">Polymorphism</td>
<td align="left" colspan="1" rowspan="1">1.397</td>
<td align="left" colspan="1" rowspan="1">0.864</td>
<td align="left" colspan="1" rowspan="1">Highly conserved</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:15%">Family 2</td>
<td align="left" colspan="1" rowspan="1">1 &amp; 2</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">c.4735C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.Arg1579<xref ref-type="fn" rid="acn3372-note-0004">a</xref>
</td>
<td align="left" colspan="1" rowspan="1">T: 0.000008242</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">Disease causing</td>
<td align="left" colspan="1" rowspan="1">1.616</td>
<td align="left" colspan="1" rowspan="1">0.968</td>
<td align="left" colspan="1" rowspan="1">Highly conserved</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="padding-left:15%">Family 3</td>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">rs200713724</td>
<td align="left" colspan="1" rowspan="1">c.3482T&gt;C</td>
<td align="left" colspan="1" rowspan="1">p.Met1161Thr</td>
<td align="left" colspan="1" rowspan="1">C: 0.0002231</td>
<td align="left" colspan="1" rowspan="1">Probably damaging</td>
<td align="left" colspan="1" rowspan="1">0.998/0.993</td>
<td align="left" colspan="1" rowspan="1">Deleterious</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">Disease causing</td>
<td align="left" colspan="1" rowspan="1">4.48</td>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">Highly conserved</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">c.4709C&gt;A</td>
<td align="left" colspan="1" rowspan="1">p.Thr1570Lys</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">Probably damaging</td>
<td align="left" colspan="1" rowspan="1">1.00/0.976</td>
<td align="left" colspan="1" rowspan="1">Deleterious</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">Disease causing</td>
<td align="left" colspan="1" rowspan="1">5.94</td>
<td align="left" colspan="1" rowspan="1">0.99</td>
<td align="left" colspan="1" rowspan="1">Highly conserved</td>
</tr>
<tr>
<td align="left" colspan="14" rowspan="1">Compound heterozygous variants in various databases included in the study</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="padding-left:15%">Epi4K 1</td>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">rs151090729</td>
<td align="left" colspan="1" rowspan="1">c.4984G&gt;A</td>
<td align="left" colspan="1" rowspan="1">p.Gly1662Ser</td>
<td align="left" colspan="1" rowspan="1">0.0013</td>
<td align="left" colspan="1" rowspan="1">Probably damaging</td>
<td align="left" colspan="1" rowspan="1">1/1</td>
<td align="left" colspan="1" rowspan="1">Deleterious</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">Disease causing</td>
<td align="left" colspan="1" rowspan="1">6.075</td>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">Highly conserved</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">c.1529C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.Pro510Leu</td>
<td align="left" colspan="1" rowspan="1">0.00001664</td>
<td align="left" colspan="1" rowspan="1">Possibly damaging</td>
<td align="left" colspan="1" rowspan="1">0.899/0.382</td>
<td align="left" colspan="1" rowspan="1">Deleterious</td>
<td align="left" colspan="1" rowspan="1">0.01</td>
<td align="left" colspan="1" rowspan="1">Polymorphism</td>
<td align="left" colspan="1" rowspan="1">0.936</td>
<td align="left" colspan="1" rowspan="1">0.009</td>
<td align="left" colspan="1" rowspan="1">Moderately conserved</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="padding-left:15%">Epi4K 2</td>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">rs145694222</td>
<td align="left" colspan="1" rowspan="1">c.2842G&gt;C</td>
<td align="left" colspan="1" rowspan="1">p.Val948Leu</td>
<td align="left" colspan="1" rowspan="1">0.00043</td>
<td align="left" colspan="1" rowspan="1">Benign</td>
<td align="left" colspan="1" rowspan="1">0.120/0.049</td>
<td align="left" colspan="1" rowspan="1">Tolerated</td>
<td align="left" colspan="1" rowspan="1">0.12</td>
<td align="left" colspan="1" rowspan="1">Polymorphism</td>
<td align="left" colspan="1" rowspan="1">0.128</td>
<td align="left" colspan="1" rowspan="1">0.009</td>
<td align="left" colspan="1" rowspan="1">Moderately conserved</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2</td>
<td align="left" colspan="1" rowspan="1">rs151153639</td>
<td align="left" colspan="1" rowspan="1">c.1453C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.Arg485Cys</td>
<td align="left" colspan="1" rowspan="1">0.0007</td>
<td align="left" colspan="1" rowspan="1">Probably damaging</td>
<td align="left" colspan="1" rowspan="1">0.983/0.405</td>
<td align="left" colspan="1" rowspan="1">Deleterious</td>
<td align="left" colspan="1" rowspan="1">0.01</td>
<td align="left" colspan="1" rowspan="1">Disease causing</td>
<td align="left" colspan="1" rowspan="1">2.17</td>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">Highly conserved</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="padding-left:15%">dbGaP 1</td>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="fn" rid="acn3372-note-0004">a</xref>rs11711062</td>
<td align="left" colspan="1" rowspan="1">c.4009T&gt;A</td>
<td align="left" colspan="1" rowspan="1">p.Ser1337Thr</td>
<td align="left" colspan="1" rowspan="1">0.0035</td>
<td align="left" colspan="1" rowspan="1">Benign</td>
<td align="left" colspan="1" rowspan="1">0.059/0.050</td>
<td align="left" colspan="1" rowspan="1">Tolerated</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">Polymorphism</td>
<td align="left" colspan="1" rowspan="1">−1.929</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">Weakly conserved</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2</td>
<td align="left" colspan="1" rowspan="1">rs150923753</td>
<td align="left" colspan="1" rowspan="1">c.1141A&gt;G</td>
<td align="left" colspan="1" rowspan="1">p.Ile381Val</td>
<td align="left" colspan="1" rowspan="1">0.0007</td>
<td align="left" colspan="1" rowspan="1">Probably damaging</td>
<td align="left" colspan="1" rowspan="1">0.995/0.992</td>
<td align="left" colspan="1" rowspan="1">Deleterious</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">Disease causing</td>
<td align="left" colspan="1" rowspan="1">5.017</td>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">Highly conserved</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="padding-left:15%">dbGaP 2</td>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">rs138413438</td>
<td align="left" colspan="1" rowspan="1">c.2972C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.Pro991Leu</td>
<td align="left" colspan="1" rowspan="1">0.00062</td>
<td align="left" colspan="1" rowspan="1">Possibly damaging</td>
<td align="left" colspan="1" rowspan="1">0.985/0.710</td>
<td align="left" colspan="1" rowspan="1">Deleterious</td>
<td align="left" colspan="1" rowspan="1">0.01</td>
<td align="left" colspan="1" rowspan="1">Polymorphism</td>
<td align="left" colspan="1" rowspan="1">1.9</td>
<td align="left" colspan="1" rowspan="1">0.01</td>
<td align="left" colspan="1" rowspan="1">Highly conserved</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">c.2470C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.His824Tyr</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">Benign</td>
<td align="left" colspan="1" rowspan="1">0.012/0.038</td>
<td align="left" colspan="1" rowspan="1">Tolerated</td>
<td align="left" colspan="1" rowspan="1">0.06</td>
<td align="left" colspan="1" rowspan="1">Polymorphism</td>
<td align="left" colspan="1" rowspan="1">−1.277</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">Weakly conserved</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:15%">dbGaP 3</td>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="fn" rid="acn3372-note-0004">a</xref>rs11711062</td>
<td align="left" colspan="1" rowspan="1">c.4009T&gt;A</td>
<td align="left" colspan="1" rowspan="1">p.Ser1337Thr</td>
<td align="left" colspan="1" rowspan="1">0.0035</td>
<td align="left" colspan="1" rowspan="1">Benign</td>
<td align="left" colspan="1" rowspan="1">0.059/0.050</td>
<td align="left" colspan="1" rowspan="1">Tolerated</td>
<td align="left" colspan="1" rowspan="1">0.3</td>
<td align="left" colspan="1" rowspan="1">Polymorphism</td>
<td align="left" colspan="1" rowspan="1">−1.929</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">Weakly conserved</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">2</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">c.2052G&gt;A</td>
<td align="left" colspan="1" rowspan="1">p.Met684Ile</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">Possibly damaging</td>
<td align="left" colspan="1" rowspan="1">0.584/0.138</td>
<td align="left" colspan="1" rowspan="1">Tolerated</td>
<td align="left" colspan="1" rowspan="1">0.06</td>
<td align="left" colspan="1" rowspan="1">Disease causing</td>
<td align="left" colspan="1" rowspan="1">5.593</td>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">Highly conserved</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="acn3372-note-0004">
<label>a</label>
<p>Identical variants in different cases.</p>
</fn>
<fn id="acn3372-note-0005">
<p>phyloP (values between −14 and +6) separately measures conservation at individual columns, ignoring the effects of their neighbors. Moreover, phyloP can not only measure conservation (slower evolution than expected under neutral drift) but also acceleration (faster than expected). Sites predicted to be conserved are assigned positive scores, while sites predicted to be fast‐evolving are assigned negative scores.</p>
</fn>
<fn id="acn3372-note-0006">
<p>phastCons values vary between 0 and 1 and reflect the probability that each nucleotide belongs to a conserved element, based on the multiple alignment of genome sequences of 46 different species (the closer the value is to 1, the more probable the nucleotide is conserved). It considers not just each individual alignment column, but also its flanking columns.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<fig fig-type="Figure" id="acn3372-fig-0002" orientation="portrait" position="float" xml:lang="en">
<label>Figure 2</label>
<caption>
<p>Location of <italic><styled-content style="fixed-case">SCN</styled-content>10</italic> variants detected in the nine presented subjects.</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="ACN3-4-26-g002"></graphic>
</fig>
</sec>
<sec id="acn3372-sec-0007">
<title>Discussion</title>
<p>Two exonic nonsynonymous homozygous variants contained within runs of homozygosity, were identified in Family 1, namely <italic>DYNC2H</italic>: c.12254G&gt;A; p.Arg4085His and <italic>SCN10A</italic>: c.4514C&gt;T; p.Thr1505Met. Although the <italic>DYNC2H</italic> variant co‐segregates with the phenotype in the family and was absent in 400 ethnically matched control chromosomes, mutations in <italic>DYNC2H</italic> are associated with asphyxiating thoracic dystrophy and short rib‐polydactyly type III,<xref ref-type="ref" rid="acn3372-bib-0006">6</xref>, <xref ref-type="ref" rid="acn3372-bib-0007">7</xref> the features of which were absent in the two girls. On the other hand, the <italic>SCN10A</italic> variant segregated with the disease phenotype, was not detected in 600 ethnically matched control chromosomes, changed a highly conserved amino acid<xref ref-type="ref" rid="acn3372-bib-0008">8</xref> and was predicted to be damaging<xref ref-type="ref" rid="acn3372-bib-0009">9</xref>, <xref ref-type="ref" rid="acn3372-bib-0010">10</xref> (Table <xref ref-type="table-wrap" rid="acn3372-tbl-0002">2</xref>). The variant affects a residue between helices S1 and S2 of repeat domain IV of the sodium channel (Fig. <xref ref-type="fig" rid="acn3372-fig-0002">2</xref>), putatively in an extracellular position. Accordingly, the <italic>SCN10A</italic> variant was considered the best candidate gene responsible for the phenotype in this family.</p>
<p>In Family 2, two exonic nonsynonymous homozygous variants contained within runs of homozygosity, namely <italic>LAMB2</italic>: c.4981C&gt;T; p.Arg1661Trp and <italic>SCN10A</italic>: c.4735C&gt;T; p.Arg1579*. Both variants co‐segregated with the phenotype and were absent in 400 ethnically matched control chromosomes and publically available databases. However, the <italic>LAMB2</italic> variant is predicted to be benign<xref ref-type="ref" rid="acn3372-bib-0009">9</xref>, <xref ref-type="ref" rid="acn3372-bib-0010">10</xref> and affects a residue that is not evolutionary conserved.<xref ref-type="ref" rid="acn3372-bib-0008">8</xref> Moreover, mutations in <italic>LAMB2</italic> are associated autosomal recessive Pierson syndrome (MIM 609409) and nephrotic sydrome type 5, with or without ocular abnormalities (MIM 614199).<xref ref-type="ref" rid="acn3372-bib-0011">11</xref> On the other hand, the <italic>SCN10A</italic> variant affects the voltage‐sensor helix S4 in Domain IV (Fig. <xref ref-type="fig" rid="acn3372-fig-0002">2</xref>), causing protein termination at residue 1579 and putatively producing a protein missing 377 amino acids (20%) of its C terminus and is possibly subject to nonsense‐mediated mRNA decay. Accordingly, the <italic>SCN10A</italic> variant was considered the best candidate gene responsible for the phenotype in this family.</p>
<p>Since Family 3 does not exhibit consanguinity, WES data could not be filtered for homozygous variants within runs of homozygosity and the analyses were focused on rare damaging variants including compound heterozygous variants. Exonic nonsynonymous compound heterozygous variants were identified in two genes, namely <italic>SASH1</italic>: c.2458C&gt;T; p.Arg820Trp and c.2995G&gt;A; p.Gly999Arg, and in <italic>SCN10A</italic>: c.3482T&gt;C; p.Met1161Thr and c.4709C&gt;A; p.Thr1570Lys. <italic>SASH1</italic> is a tumor suppressor gene, involved in toll‐like receptor signaling pathway and is significantly down‐regulated in breast tumor tissues and breast cancer cell lines,<xref ref-type="ref" rid="acn3372-bib-0012">12</xref> and is thus unlikely to be the offending gene in this patient. On the other hand, both <italic>SCN10A</italic> variants are damaging according to the prediction tools,<xref ref-type="ref" rid="acn3372-bib-0009">9</xref>, <xref ref-type="ref" rid="acn3372-bib-0010">10</xref> extremely rare, affect highly conserved residues<xref ref-type="ref" rid="acn3372-bib-0008">8</xref> and co‐segregate with the disease phenotype in the family (Table <xref ref-type="table-wrap" rid="acn3372-tbl-0002">2</xref>). Since seizures and pain disorders occur due to mutations highly homologous sodium channel gene, <italic>SCN9A</italic>, that is expressed in dorsal root ganglion,<xref ref-type="ref" rid="acn3372-bib-0013">13</xref>, <xref ref-type="ref" rid="acn3372-bib-0014">14</xref>, <xref ref-type="ref" rid="acn3372-bib-0015">15</xref>
<italic>SCN10A</italic> was considered the best candidate gene in this family.</p>
<p>Voltage‐gated sodium channels (VGSC) are responsible for initiating and propagating action potentials in neurons and other excitable cells. Their pore‐forming alpha subunits are integral membrane glycoproteins encoded by a family comprised of nine highly conserved genes, and are sufficient for channel expression.<xref ref-type="ref" rid="acn3372-bib-0016">16</xref>, <xref ref-type="ref" rid="acn3372-bib-0017">17</xref>, <xref ref-type="ref" rid="acn3372-bib-0018">18</xref>, <xref ref-type="ref" rid="acn3372-bib-0019">19</xref> Their function includes ion conductance, pore gating and pore regulation. They share a conserved basic structure of about 2000 amino‐acids arranged in four homologous domains (I–IV), each containing six evolutionarily conserved transmembrane alpha helices (S1‐S6) with S4 harboring the voltage sensor<xref ref-type="ref" rid="acn3372-bib-0020">20</xref> (Fig. <xref ref-type="fig" rid="acn3372-fig-0002">2</xref>). The associated regulatory beta subunits (beta1‐beta4) modulates the properties, kinetics, and trafficking of the pore‐forming alpha subunit.<xref ref-type="ref" rid="acn3372-bib-0021">21</xref>
<italic>SCN10A</italic> encodes the alpha subunit of the VGSC, N<sub>av</sub>1.8 that is expressed in nociceptors that transmit pain signals, in C‐fibers from dorsal root ganglia, heart muscle, skeletal muscle, and neuronal tissues.<xref ref-type="ref" rid="acn3372-bib-0022">22</xref> Mutations in VGSC lead to either hypoactivity or hyperactivity of the sodium channels. Monoallelic VGSC variant are associated with epilepsy,<xref ref-type="ref" rid="acn3372-bib-0023">23</xref> cardiac conduction defects,<xref ref-type="ref" rid="acn3372-bib-0024">24</xref> skeletal muscle channelopathies,<xref ref-type="ref" rid="acn3372-bib-0025">25</xref> and peripheral pain disorders,<xref ref-type="ref" rid="acn3372-bib-0026">26</xref> based on their tissue‐specific expression. Inherited mutations cause less severe disease than de novo mutations, and truncating mutations are associated with the most severe phenotypes.<xref ref-type="ref" rid="acn3372-bib-0027">27</xref> Most VGSC mutations are heterozygous, with a few exceptions such as, congenital insensitivity to pain due to biallelic <italic>SCN9A</italic> mutations,<xref ref-type="ref" rid="acn3372-bib-0026">26</xref> sick sinus syndrome due to biallelic <italic>SCN5A</italic> mutations<xref ref-type="ref" rid="acn3372-bib-0028">28</xref> and biallelic mutations in <italic>SCN4A</italic> causing myasthenic syndrome with period paralysis,<xref ref-type="ref" rid="acn3372-bib-0029">29</xref> or congenital myopathy.<xref ref-type="ref" rid="acn3372-bib-0030">30</xref>
</p>
<p>To date, no known neurological diseases, particularly seizures, have been associated with biallelic <italic>SCN10A</italic> mutations. Heterozygous gain‐of‐function <italic>SCN10A</italic> mutations account for about 5% of small fiber neuropathies, characterized by severe pain attacks and a reduced ability to differentiate between hot and cold (Familial Episodic Pain Syndrome 2, MIM 61551).<xref ref-type="ref" rid="acn3372-bib-0031">31</xref>, <xref ref-type="ref" rid="acn3372-bib-0032">32</xref> These mutations cause the sodium channels to open more readily, increasing the flow of sodium ions that produce nerve impulses within nociceptors and causing increased sensitivity to pain. <italic>SCN10A</italic> plays a role in maintaining normal heart rhythm.<xref ref-type="ref" rid="acn3372-bib-0033">33</xref>, <xref ref-type="ref" rid="acn3372-bib-0034">34</xref> Certain heterozygous <italic>SCN10A</italic> polymorphisms have been associated with increased risk of cardiac arrhythmia, including Brugada disorder (MIM 601144). These were hypothesized to disrupt the electrical signals that control heartbeat, causing “heart block” arrhythmias due to slowed or interrupted cardiac conduction.<xref ref-type="ref" rid="acn3372-bib-0035">35</xref> Loss‐of‐function effects for these heterozygous variants is suspected.<xref ref-type="ref" rid="acn3372-bib-0036">36</xref> A recent study suggests that variants in <italic>SCN10A</italic> are involved in the genesis of atrial fibrillation.<xref ref-type="ref" rid="acn3372-bib-0037">37</xref> Interestingly, in neurons derived from a mouse homozygous of Thr790Ala variant, current clamp recordings revealed heightened excitability of the neurons with long‐duration actions potentials, implicating a role of <italic>SCN10A</italic> in modulating the activity of CNS neurons.</p>
<p>In all three families presented, the obligate heterozygotes had no complaints of episodic pain and there was no family history of sudden death or arhythmia. Thus it appears that the presence of these variants in heterozygosity is not associated with a detectable clinical phenotype. Most of the biallelic variants in the three families are in the ion transport domain of <italic>SCN10A</italic>. further genotype‐phenotype correlation would require identification of additional cases. Since other sodium channel genes, such as <italic>SCN1A</italic> and <italic>SCN2A</italic> have been associated with epilepsy,<xref ref-type="ref" rid="acn3372-bib-0023">23</xref>, <xref ref-type="ref" rid="acn3372-bib-0025">25</xref> and <italic>SCN1A</italic> leading to Dravet syndrome is classically precipitated by fever, it is interesting that another refractory epileptic encephalopathy triggered by fever (FIRES) has now been associate with another sodium channel gene.<xref ref-type="ref" rid="acn3372-bib-0014">14</xref> In addition, the expression of <italic>SCN10A</italic> in CNS neurons, as well as in the developing brain provides biological plausibility for the phenotype produced by the biallelic mutations.<xref ref-type="ref" rid="acn3372-bib-0038">38</xref>, <xref ref-type="ref" rid="acn3372-bib-0039">39</xref>, <xref ref-type="ref" rid="acn3372-bib-0040">40</xref>, <xref ref-type="ref" rid="acn3372-bib-0041">41</xref>
</p>
<p>Epileptic seizures affect 7–46% of children with ASD, especially those with intellectual developmental disorder and ASD occurs in 15–35% of those with epilepsy.<xref ref-type="ref" rid="acn3372-bib-0042">42</xref> Examination of databases containing whole genome or whole exome data for patients with epilepsy, ASD or both for compound heterozygosity for mutations within genes identified through homozygosity studies would be quite useful. In this study the identification of compound heterozygosity in two patients with LGS and infantile spasms and three patients with ASD further implicates <italic>SCN10A</italic> in these disorders.</p>
<p>In conclusion, through an international collaboration, we have identified four patients with biallelic <italic>SCN10A</italic> variants who presented with epileptic seizures. The review of three different publically available disease databases has added several other patients, although the variants may not be responsible for the phenotype. Since epilepsy is observed along with intellectual impairment and peripheral neuropathy, biallelic <italic>SCN10A</italic> mutations likely interfere with normal functioning of this sodium channel, resulting in aberrant transmission of nerve impulses.</p>
</sec>
<sec id="acn3372-sec-0009">
<title>Author Contribution</title>
<p>JAA, MCM and HES conceptulized the sudy and provided guidance and supervision. MK, AS, JS, YAS, WB, JCM, YD, CTR, and JBR analyzed exomes, validated variants and examined seggregation. MK, JSO and CTR performed molecular genetics experiments for biological validation of results. JT, AS, TBO, AMP, CC, JAA, LF, WG and HES ascertained, recruited, and clinically evaluated patients. AC and AB examined datasets. NISC performed NGS data analysis. MK, YAS, and JAA performed homozygosity mapping. MK, JT, AS, AC, JS, TBO, YAS, HB, WB, JCM, AMP, JSO, YD, CC, CTR, LF, JBR, WG, AB, MCM, and HES contributed to the manuscript writing and/or review.</p>
</sec>
<sec id="acn3372-sec-0010">
<title>Conflict of Interest</title>
<p>All authors report no conflict of interest.</p>
</sec>
</body>
<back>
<ack id="acn3372-sec-0008">
<title>Acknowledgment</title>
<p>This publication was made possible in part by Qatar National Research Fund (QNRF) NPRP grant 09‐367‐3‐087 (MK and HE) and NPRP grant 6‐359‐3‐095 (HE and AGB) and by the generous support of the Shafallah Center Foundation, Doha, Qatar. It was also supported by NIH 1R01 NS064159‐01A1 (AGB) and 5R21MH100086‐02 and the National Human Genome Research Institute Intramural Research Program. The support for the Autism Sequencing Collaborative was provided by grants R01‐MH089208 awarded to Mark Daly, R01‐MH089175 awarded to Richard Gibbs, R01‐MH089025 awarded to Joseph Buxbaum, R01‐MH089004 awarded to Gerard Schellenberg and R01‐MH089482 awarded to James Sutcliffe. Our appreciation to the Epilepsy Epi4K consortium: Discovery in Epilepsy study (NINDS U01‐NS077303) and the Epilepsy Genome/Phenome Project (EPGP‐NINDS U01‐NS053998). Special thanks to Maryam Al‐Mutawa for her help with the figures and to Hibah Shaath for her valuable contribution to the preparation of this manuscript. This manuscript is dedicated to the memory of Dr. Jamil Al‐Alami who sadly passed away during the work on this project. Jamil was highly regarded as a physician, colleague, friend, and overall a great person.</p>
</ack>
<ref-list content-type="cited-references" id="acn3372-bibl-0001">
<title>References</title>
<ref id="acn3372-bib-0001">
<label>1</label>
<mixed-citation id="acn3372-cit-0001" publication-type="journal">
<string-name>
<surname>Seelow</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Schuelke</surname>
<given-names>M</given-names>
</string-name>. <article-title>HomozygosityMapper2012–bridging the gap between homozygosity mapping and deep sequencing</article-title>. <source/>Nucleic Acids Res
<year>2012</year>;<volume>40</volume>:<fpage>W516</fpage>–<lpage>W520</lpage>.<pub-id pub-id-type="pmid">22669902</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0002">
<label>2</label>
<mixed-citation id="acn3372-cit-0002" publication-type="journal">
<string-name>
<surname>Seelow</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Schuelke</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hildebrandt</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Nurnberg</surname>
<given-names>P</given-names>
</string-name>. <article-title>HomozygosityMapper–an interactive approach to homozygosity mapping</article-title>. <source/>Nucleic Acids Res
<year>2009</year>;<volume>37</volume>:<fpage>W593</fpage>–<lpage>W599</lpage>.<pub-id pub-id-type="pmid">19465395</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0003">
<label>3</label>
<mixed-citation id="acn3372-cit-0003" publication-type="journal">
<collab collab-type="authors">Epi4K Consortium</collab>
. <article-title>Epi4K: gene discovery in 4,000 genomes</article-title>. <source/>Epilepsia. <year>2012</year>;<volume>53</volume>:<fpage>1457</fpage>–<lpage>1467</lpage>.<pub-id pub-id-type="pmid">22642626</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0004">
<label>4</label>
<mixed-citation id="acn3372-cit-0004" publication-type="journal">
<collab collab-type="authors">Epi4K Consortium</collab>
, Epilepsy Phenome/Genome Project, <string-name>
<surname>Allen</surname>
<given-names>AS</given-names>
</string-name>, et al. <article-title>De novo mutations in epileptic encephalopathies</article-title>. <source/>Nature
<year>2013</year>;<volume>501</volume>:<fpage>217</fpage>–<lpage>221</lpage>.<pub-id pub-id-type="pmid">23934111</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0005">
<label>5</label>
<mixed-citation id="acn3372-cit-0005" publication-type="journal">
<collab collab-type="authors">EuroEPINOMICS‐RES Consortium</collab>
, Epilepsy Phenome/Genome Project, Epi4K Consortium. <article-title>De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies</article-title>. <source/>Am J Hum Genet
<year>2014</year>;<volume>95</volume>:<fpage>360</fpage>–<lpage>370</lpage>.<pub-id pub-id-type="pmid">25262651</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0006">
<label>6</label>
<mixed-citation id="acn3372-cit-0006" publication-type="journal">
<string-name>
<surname>Dagoneau</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Goulet</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Geneviève</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>DYNC2H1 mutations cause asphyxiating thoracic dystrophy and short rib‐polydactyly syndrome, type III</article-title>. <source/>Am J Hum Genet
<year>2009</year>;<volume>84</volume>:<fpage>706</fpage>–<lpage>711</lpage>.<pub-id pub-id-type="pmid">19442771</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0007">
<label>7</label>
<mixed-citation id="acn3372-cit-0007" publication-type="journal">
<string-name>
<surname>Merrill</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Merriman</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Farrington‐Rock</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Ciliary abnormalities due to defects in the retrograde transport protein DYNC2H1 in short‐rib polydactyly syndrome</article-title>. <source/>Am J Hum Genet
<year>2009</year>;<volume>84</volume>:<fpage>542</fpage>–<lpage>549</lpage>.<pub-id pub-id-type="pmid">19361615</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0008">
<label>8</label>
<mixed-citation id="acn3372-cit-0008" publication-type="journal">
<string-name>
<surname>Pollard</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Hubisz</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Rosenbloom</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Siepel</surname>
<given-names>A</given-names>
</string-name>. <article-title>Detection of nonneutral substitution rates on mammalian phylogenies</article-title>. <source/>Genome Res
<year>2010</year>;<volume>20</volume>:<fpage>110</fpage>–<lpage>121</lpage>.<pub-id pub-id-type="pmid">19858363</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0009">
<label>9</label>
<mixed-citation id="acn3372-cit-0009" publication-type="journal">
<string-name>
<surname>Kumar</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Henikoff</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ng</surname>
<given-names>PC</given-names>
</string-name>. <article-title>Predicting the effects of coding non‐synonymous variants on protein function using the SIFT algorithm</article-title>. <source/>Nat Protoc
<year>2009</year>;<volume>4</volume>:<fpage>1073</fpage>–<lpage>1081</lpage>.<pub-id pub-id-type="pmid">19561590</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0010">
<label>10</label>
<mixed-citation id="acn3372-cit-0010" publication-type="journal">
<string-name>
<surname>Adzhubei</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Jordan</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Sunyaev</surname>
<given-names>SR</given-names>
</string-name>. <article-title>Predicting functional effect of human missense mutations using PolyPhen‐2</article-title>. <source/>Curr Protoc in Human Genet/editorial board, Jonathan L. Haines… [et al.]. <year>2013</year>;Chapter <volume>7</volume>:<fpage>Unit7.20</fpage>.<pub-id pub-id-type="pmid">23315928</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0011">
<label>11</label>
<mixed-citation id="acn3372-cit-0011" publication-type="journal">
<string-name>
<surname>Matejas</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Hinkes</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Alkandari</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Mutations in the human laminin beta2 (<italic>LAMB2</italic>) gene and the associated phenotypic spectrum</article-title>. <source/>Hum Mutat
<year>2010</year>;<volume>31</volume>:<fpage>992</fpage>–<lpage>1002</lpage>.<pub-id pub-id-type="pmid">20556798</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0012">
<label>12</label>
<mixed-citation id="acn3372-cit-0012" publication-type="journal">
<string-name>
<surname>Zeller</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hinzmann</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Seitz</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>SASH1: a candidate tumor suppressor gene on chromosome 6q24.3 is downregulated in breast cancer</article-title>. <source/>Oncogene
<year>2003</year>;<volume>22</volume>:<fpage>2972</fpage>–<lpage>2983</lpage>.<pub-id pub-id-type="pmid">12771949</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0013">
<label>13</label>
<mixed-citation id="acn3372-cit-0013" publication-type="journal">
<string-name>
<surname>Cox</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Reimann</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Nicholas</surname>
<given-names>AK</given-names>
</string-name>, et al. <article-title>An SCN9A channelopathy causes congenital inability to experience pain</article-title>. <source/>Nature
<year>2006</year>;<volume>444</volume>:<fpage>894</fpage>–<lpage>898</lpage>.<pub-id pub-id-type="pmid">17167479</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0014">
<label>14</label>
<mixed-citation id="acn3372-cit-0014" publication-type="journal">
<string-name>
<surname>Singh</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Pappas</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Dahle</surname>
<given-names>EJ</given-names>
</string-name>, et al. <article-title>A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome</article-title>. <source/>PLoS Genet
<year>2009</year>;<volume>5</volume>:<fpage>e1000649</fpage>.<pub-id pub-id-type="pmid">19763161</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0015">
<label>15</label>
<mixed-citation id="acn3372-cit-0015" publication-type="journal">
<string-name>
<surname>Cox</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Sheynin</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Shorer</surname>
<given-names>Z</given-names>
</string-name>, et al. <article-title>Congenital insensitivity to pain: novel SCN9A missense and in‐frame deletion mutations</article-title>. <source/>Hum Mutat
<year>2010</year>;<volume>31</volume>:<fpage>E1670</fpage>–<lpage>E1686</lpage>.<pub-id pub-id-type="pmid">20635406</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0016">
<label>16</label>
<mixed-citation id="acn3372-cit-0016" publication-type="journal">
<string-name>
<surname>Catterall</surname>
<given-names>WA</given-names>
</string-name>. <article-title>Voltage‐gated sodium channels at 60: structure, function and pathophysiology</article-title>. <source/>J Physiol
<year>2012</year>;<volume>590</volume>:<fpage>2577</fpage>–<lpage>2589</lpage>.<pub-id pub-id-type="pmid">22473783</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0017">
<label>17</label>
<mixed-citation id="acn3372-cit-0017" publication-type="journal">
<string-name>
<surname>Catterall</surname>
<given-names>WA</given-names>
</string-name>. <article-title>Sodium channels, inherited epilepsy, and antiepileptic drugs</article-title>. <source/>Annu Rev Pharmacol Toxicol. <year>2014</year>;<volume>54</volume>:<fpage>317</fpage>–<lpage>338</lpage>.<pub-id pub-id-type="pmid">24392695</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0018">
<label>18</label>
<mixed-citation id="acn3372-cit-0018" publication-type="journal">
<string-name>
<surname>Catterall</surname>
<given-names>WA</given-names>
</string-name>. <article-title>Signaling complexes of voltage‐gated sodium and calcium channels</article-title>. <source/>Neurosci Lett
<year>2010</year>;<volume>486</volume>:<fpage>107</fpage>–<lpage>116</lpage>.<pub-id pub-id-type="pmid">20816922</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0019">
<label>19</label>
<mixed-citation id="acn3372-cit-0019" publication-type="journal">
<string-name>
<surname>Catterall</surname>
<given-names>WA</given-names>
</string-name>. <article-title>Structure and function of voltage‐gated sodium channels at atomic resolution</article-title>. <source/>Exp Physiol
<year>2014</year>;<volume>99</volume>:<fpage>35</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">24097157</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0020">
<label>20</label>
<mixed-citation id="acn3372-cit-0020" publication-type="journal">
<string-name>
<surname>Catterall</surname>
<given-names>WA</given-names>
</string-name>. <article-title>From ionic currents to molecular mechanisms: the structure and function of voltage‐gated sodium channels</article-title>. <source/>Neuron
<year>2000</year>;<volume>26</volume>:<fpage>13</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">10798388</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0021">
<label>21</label>
<mixed-citation id="acn3372-cit-0021" publication-type="journal">
<string-name>
<surname>Eijkelkamp</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Linley</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Baker</surname>
<given-names>MD</given-names>
</string-name>, et al. <article-title>Neurological perspectives on voltage‐gated sodium channels</article-title>. <source/>Brain
<year>2012</year>;<volume>135</volume>:<fpage>2585</fpage>–<lpage>2612</lpage>.<pub-id pub-id-type="pmid">22961543</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0022">
<label>22</label>
<mixed-citation id="acn3372-cit-0022" publication-type="journal">
<string-name>
<surname>Moldovan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Alvarez</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pinchenko</surname>
<given-names>V</given-names>
</string-name>, et al. <article-title>Na(v)1.8 channelopathy in mutant mice deficient for myelin protein zero is detrimental to motor axons</article-title>. <source/>Brain
<year>2011</year>;<volume>134</volume>:<fpage>585</fpage>–<lpage>601</lpage>.<pub-id pub-id-type="pmid">21169333</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0023">
<label>23</label>
<mixed-citation id="acn3372-cit-0023" publication-type="journal">
<string-name>
<surname>Harkin</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>McMahon</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Iona</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>The spectrum of SCN1A‐related infantile epileptic encephalopathies</article-title>. <source/>Brain
<year>2007</year>;<volume>130</volume>:<fpage>843</fpage>–<lpage>852</lpage>.<pub-id pub-id-type="pmid">17347258</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0024">
<label>24</label>
<mixed-citation id="acn3372-cit-0024" publication-type="journal">
<string-name>
<surname>Amin</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Asghari‐Roodsari</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>HL</given-names>
</string-name>. <article-title>Cardiac sodium channelopathies</article-title>. <source/>Pflugers Arch
<year>2010</year>;<volume>460</volume>:<fpage>223</fpage>–<lpage>237</lpage>.<pub-id pub-id-type="pmid">20091048</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0025">
<label>25</label>
<mixed-citation id="acn3372-cit-0025" publication-type="journal">
<string-name>
<surname>Jurkat‐Rott</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Holzherr</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Fauler</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lehmann‐Horn</surname>
<given-names>F</given-names>
</string-name>. <article-title>Sodium channelopathies of skeletal muscle result from gain or loss of function</article-title>. <source/>Pflugers Arch
<year>2010</year>;<volume>460</volume>:<fpage>239</fpage>–<lpage>248</lpage>.<pub-id pub-id-type="pmid">20237798</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0026">
<label>26</label>
<mixed-citation id="acn3372-cit-0026" publication-type="journal">
<string-name>
<surname>Lampert</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>O'Reilly</surname>
<given-names>AO</given-names>
</string-name>, <string-name>
<surname>Reeh</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Leffler</surname>
<given-names>A</given-names>
</string-name>. <article-title>Sodium channelopathies and pain</article-title>. <source/>Pflugers Arch
<year>2010</year>;<volume>460</volume>:<fpage>249</fpage>–<lpage>263</lpage>.<pub-id pub-id-type="pmid">20101409</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0027">
<label>27</label>
<mixed-citation id="acn3372-cit-0027" publication-type="journal">
<string-name>
<surname>Brunklaus</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ellis</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Reavey</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>Genotype phenotype associations across the voltage‐gated sodium channel family</article-title>. <source/>J Med Genet
<year>2014</year>;<volume>51</volume>:<fpage>650</fpage>–<lpage>658</lpage>.<pub-id pub-id-type="pmid">25163687</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0028">
<label>28</label>
<mixed-citation id="acn3372-cit-0028" publication-type="journal">
<string-name>
<surname>Benson</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Dyment</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A)</article-title>. <source/>J Clin Invest
<year>2003</year>;<volume>112</volume>:<fpage>1019</fpage>–<lpage>1028</lpage>.<pub-id pub-id-type="pmid">14523039</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0029">
<label>29</label>
<mixed-citation id="acn3372-cit-0029" publication-type="journal">
<string-name>
<surname>Habbout</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Poulin</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Rivier</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>A recessive Nav1.4 mutation underlies congenital myasthenic syndrome with periodic paralysis</article-title>. <source/>Neurology. <year>2016</year>;<volume>86</volume>:<fpage>161</fpage>–<lpage>169</lpage>.<pub-id pub-id-type="pmid">26659129</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0030">
<label>30</label>
<mixed-citation id="acn3372-cit-0030" publication-type="journal">
<string-name>
<surname>Zaharieva</surname>
<given-names>IT</given-names>
</string-name>, <string-name>
<surname>Thor</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Oates</surname>
<given-names>EC</given-names>
</string-name>, et al. <article-title>Loss‐of‐function mutations in SCN4A cause severe foetal hypokinesia or ‘classical’ congenital myopathy</article-title>. <source/>Brain. <year>2016</year>;<volume>139</volume>:<fpage>674</fpage>–<lpage>691</lpage>.<pub-id pub-id-type="pmid">26700687</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0031">
<label>31</label>
<mixed-citation id="acn3372-cit-0031" publication-type="journal">
<string-name>
<surname>Faber</surname>
<given-names>CG</given-names>
</string-name>, <string-name>
<surname>Lauria</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Merkies</surname>
<given-names>ISJ</given-names>
</string-name>, et al. <article-title>Gain‐of‐function Nav1.8 mutations in painful neuropathy</article-title>. <source/>Proc Natl Acad Sci USA. <year>2012</year>;<volume>109</volume>:<fpage>19444</fpage>–<lpage>19449</lpage>.<pub-id pub-id-type="pmid">23115331</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0032">
<label>32</label>
<mixed-citation id="acn3372-cit-0032" publication-type="journal">
<string-name>
<surname>Waxman</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Merkies</surname>
<given-names>ISJ</given-names>
</string-name>, <string-name>
<surname>Gerrits</surname>
<given-names>MM</given-names>
</string-name>, et al. <article-title>Sodium channel genes in pain‐related disorders: phenotype‐genotype associations and recommendations for clinical use</article-title>. <source/>Lancet Neurol
<year>2014</year>;<volume>13</volume>:<fpage>1152</fpage>–<lpage>1160</lpage>.<pub-id pub-id-type="pmid">25316021</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0033">
<label>33</label>
<mixed-citation id="acn3372-cit-0033" publication-type="journal">
<string-name>
<surname>Facer</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Punjabi</surname>
<given-names>PP</given-names>
</string-name>, <string-name>
<surname>Abrari</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Localisation of SCN10A gene product Na(v)1.8 and novel pain‐related ion channels in human heart</article-title>. <source/>Int Heart J
<year>2011</year>;<volume>52</volume>:<fpage>146</fpage>–<lpage>152</lpage>.<pub-id pub-id-type="pmid">21646736</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0034">
<label>34</label>
<mixed-citation id="acn3372-cit-0034" publication-type="journal">
<string-name>
<surname>Chambers</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Terracciano</surname>
<given-names>CMN</given-names>
</string-name>, et al. <article-title>Genetic variation in SCN10A influences cardiac conduction</article-title>. <source/>Nat Genet
<year>2010</year>;<volume>42</volume>:<fpage>149</fpage>–<lpage>152</lpage>.<pub-id pub-id-type="pmid">20062061</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0035">
<label>35</label>
<mixed-citation id="acn3372-cit-0035" publication-type="journal">
<string-name>
<surname>Savio‐Galimberti</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Weeke</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Muhammad</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>SCN10A/Nav1.8 modulation of peak and late sodium currents in patients with early onset atrial fibrillation</article-title>. <source/>Cardiovasc Res
<year>2014</year>;<volume>104</volume>:<fpage>355</fpage>–<lpage>363</lpage>.<pub-id pub-id-type="pmid">25053638</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0036">
<label>36</label>
<mixed-citation id="acn3372-cit-0036" publication-type="journal">
<string-name>
<surname>Hu</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Barajas‐Martínez</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Pfeiffer</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome</article-title>. <source/>J Am Coll Cardiol
<year>2014</year>;<volume>64</volume>:<fpage>66</fpage>–<lpage>79</lpage>.<pub-id pub-id-type="pmid">24998131</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0037">
<label>37</label>
<mixed-citation id="acn3372-cit-0037" publication-type="journal">
<string-name>
<surname>Jabbari</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Olesen</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Common and rare variants in SCN10A modulate the risk of atrial fibrillation</article-title>. <source/>Circ Cardiovas Genet
<year>2015</year>;<volume>8</volume>:<fpage>64</fpage>–<lpage>73</lpage>.</mixed-citation>
</ref>
<ref id="acn3372-bib-0038">
<label>38</label>
<mixed-citation id="acn3372-cit-0038" publication-type="journal">
<string-name>
<surname>Hawrylycz</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Lein</surname>
<given-names>ES</given-names>
</string-name>, <string-name>
<surname>Guillozet‐Bongaarts</surname>
<given-names>AL</given-names>
</string-name>, et al. <article-title>An anatomically comprehensive atlas of the adult human brain transcriptome</article-title>. <source/>Nature
<year>2012</year>;<volume>489</volume>:<fpage>391</fpage>–<lpage>399</lpage>.<pub-id pub-id-type="pmid">22996553</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0039">
<label>39</label>
<mixed-citation id="acn3372-cit-0039" publication-type="journal">
<string-name>
<surname>Jones</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Overly</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Sunkin</surname>
<given-names>SM</given-names>
</string-name>. <article-title>The Allen Brain Atlas: 5 years and beyond</article-title>. <source/>Nat Rev Neurosci
<year>2009</year>;<volume>10</volume>:<fpage>821</fpage>–<lpage>828</lpage>.<pub-id pub-id-type="pmid">19826436</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0040">
<label>40</label>
<mixed-citation id="acn3372-cit-0040" publication-type="journal">
<string-name>
<surname>Shen</surname>
<given-names>EH</given-names>
</string-name>, <string-name>
<surname>Overly</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>AR</given-names>
</string-name>. <article-title>The allen human brain Atlas: comprehensive gene expression mapping of the human brain</article-title>. <source/>Trends Neurosci
<year>2012</year>;<volume>35</volume>:<fpage>711</fpage>–<lpage>714</lpage>.<pub-id pub-id-type="pmid">23041053</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0041">
<label>41</label>
<mixed-citation id="acn3372-cit-0041" publication-type="journal">
<string-name>
<surname>Sunkin</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Ng</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lau</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Allen Brain Atlas: an integrated spatio‐temporal portal for exploring the central nervous system</article-title>. <source/>Nucleic Acids Res
<year>2013</year>;<volume>41</volume>:<fpage>D996</fpage>–<lpage>D1008</lpage>.<pub-id pub-id-type="pmid">23193282</pub-id></mixed-citation>
</ref>
<ref id="acn3372-bib-0042">
<label>42</label>
<mixed-citation id="acn3372-cit-0042" publication-type="journal">
<string-name>
<surname>Lo‐Castro</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Curatolo</surname>
<given-names>P</given-names>
</string-name>. <article-title>Epilepsy associated with autism and attention deficit hyperactivity disorder: is there a genetic link?</article-title>
<source/>Brain Dev
<year>2014</year>;<volume>36</volume>:<fpage>185</fpage>–<lpage>193</lpage>.<pub-id pub-id-type="pmid">23726375</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>